REAL

The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy

Szarvas, Tibor and Csizmarik, Anita and Váradi, Melinda and Fazekas, Tamás and Hüttl, András and Nyirády, Péter and Hadaschik, Boris and Grünwald, Viktor and Tschirdewahn, Stephan and Shariat, Shahrokh F and Sevcenco, Sabina and Maj-Hes, Agnieszka and Kramer, Gero (2021) The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy. Urologic Oncology, 39 (5). 296.e11-296.e19. ISSN 1078-1439

[img]
Preview
Text
Szarvas_uroloncol.pdf
Available under License Creative Commons Attribution.

Download (761kB) | Preview
Item Type: Article
Subjects: R Medicine / orvostudomány > RZ Other systems of medicine / orvostudomány egyéb területei
Depositing User: Dr. habil. Tibor Szarvas
Date Deposited: 22 Jul 2022 11:17
Last Modified: 22 Jul 2022 11:17
URI: http://real.mtak.hu/id/eprint/145106

Actions (login required)

Edit Item Edit Item